Table 3.
By intervention group (n = 73); Mixed model analysis of repeated measures
| Estimate | df | t | p value | 95% CI | |
|---|---|---|---|---|---|
| AHSS | 4.49 | 64.84 | 2.41 | 0.019* | 0.77, 8.21 |
| SCL-8D | 5.20 | 64.94 | 2.13 | 0.037* | 0.32, 10.08 |
| Anxiety | 3.23 | 63.91 | 2.44 | 0.017* | 0.59, 5.87 |
| Depression | 1.98 | 65.21 | 1.60 | 0.114 | −0.49, 4.45 |
| Total summary score | 9.40 | 65.15 | 2.28 | 0.026* | 1.16, 17.65 |
| Alcohol use | −0.02 | 50.77 | −0.24 | 0.809 | −0.15, 0.12 |
| Drug use | −0.07 | 56.18 | −0.94 | 0.351 | −0.23, 0.08 |
| Total substance score | −0.08 | 57.24 | −0.08 | 0.452 | −0.28, 0.13 |
Results presenting the difference in change over a 3-month assessment period (12 assessments) between the intervention group (TAU + IVR assessment + IVR feedback) and the control group (TAU + IVR assessment) on the following outcome variables: stress (AHSS), mental health symptoms (SCL-8D), SCL-8D sub-scores for anxiety and depression, the summary total score (including AHSS and SCL-8D) used for feedback in the intervention group, and a summarized total substance use score (including alcohol and drug use), the latter not used for feedback
AHSS Arnetz and Hasson stress questionnaire, SCL-8D eight-item version of the Symptoms Check List
*p < 0.05